Journal article

Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells

M Chircop, S Perera, A Mariana, H Lau, MPC Ma, J Gilbert, NC Jones, CP Gordon, KA Young, A Morokoff, J Sakoff, TJ O'Brien, A McCluskey, PJ Robinson

Molecular Cancer Therapeutics | AMER ASSOC CANCER RESEARCH | Published : 2011

Abstract

Inhibitors of mitotic proteins such as Aurora kinase and polo-like kinase have shown promise in preclinical or early clinical development for cancer treatment. We have reported that the MiTMAB class of dynamin small molecule inhibitors are new antimitotic agents with a novel mechanism of action, blocking cytokinesis. Here, we examined 5 of the most potent of a new series of dynamin GTPase inhibitors called dynoles. They all induced cytokinesis failure at the point of abscission, consistent with inhibition of dynamin while not affecting other cell cycle stages. All 5 dynoles inhibited cell proliferation (MTT and colony formation assays) in 11 cancer cell lines. The most potent GTPase inhibito..

View full abstract

Grants

Funding Acknowledgements

This work was supported by grants from the NSW Cancer Council Project grant (M. Chircop and J. Sakoff), James S McDonnell Foundation U.S.A. Project grant (M. Chircop, J. Sakoff, P. J. Robinson, A. McCluskey, and T. J. O'Brien), NH&MRC Project grant (P. J. Robinson and M. Chircop), and NH&MRC Career Development Award Fellowship (M. Chircop).